期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Rapid genetic diagnosis and prenatal diagnosis of spinal muscular atrophy by denaturing high-performance liquid chromatography 被引量:5
1
作者 ZHU Hai-yan WU Ling-qian +6 位作者 PAN Qian TANG Bei-sha liang de-sheng LONG Zhi-gao DAI He-ping XIA Kun XIA Jia-hui 《Chinese Medical Journal》 SCIE CAS CSCD 2006年第14期1222-1225,共4页
Spinal muscular atrophy (SMA) is a common Pautosomal recessive neuromuscular disorder (1in 6000 to 10 000 births) caused by mutations in the SMN1 gene at 5q13. More than 90%-98% of SMA patients show homozygous del... Spinal muscular atrophy (SMA) is a common Pautosomal recessive neuromuscular disorder (1in 6000 to 10 000 births) caused by mutations in the SMN1 gene at 5q13. More than 90%-98% of SMA patients show homozygous deletion of SMN1, which has proved to be useful in the diagnosis of SMA. But it is hampered because of the existence of a highly homologous gene, SMN2. Based on nucleotide mismatches between SMN1 and SMN2, the following two DNA tests are usually performed: single-strand conformational polymorphism (SSCP) and polymerase chain reaction (PCR) followed by a restriction enzyme digestion.In this study we developed a new method for rapid genetic diagnosis of SMA by denaturing high-performance liquid chromatography (DHPLC), which is based on different retention of homoduplexes and heteroduplexes in detecting the homozygous deletion of SMN1. Both genetic and prenatal diagnoses were performed successfully for a SMA family by DHPLC, which was confirmed as a rapid and effective technique for detecting the deletion of SMN1. 展开更多
关键词 spinal muscular atrophy SMA SMN1 SMN2 DHPLC gene diagnosis prenatal diagnosis
原文传递
Targeted expression of vascular endothelial growth factor 165 in the hrDNA locus mediated by hrDNA targeting vector
2
作者 liang Zong-min LUO Hong +7 位作者 YANG Yi-feng LIU Xiong-hao XIE Li XUE Zhi-gang HU Dong-xu liang de-sheng XIA Kun XIA Jia-hui 《Chinese Medical Journal》 SCIE CAS CSCD 2007年第5期427-430,共4页
Vascular endothelial growth factor (VEGF) is an angiogenic regulator that stimulates endothelial cell migration, proliferation, and angiogenesis. VEGF gene therapy is a new promising approach to induce therapeutic a... Vascular endothelial growth factor (VEGF) is an angiogenic regulator that stimulates endothelial cell migration, proliferation, and angiogenesis. VEGF gene therapy is a new promising approach to induce therapeutic angiogenesis for the treatment of ischemic myocardial and limb diseases. Recently, clinical studies have demonstrated successful outcomes using plasmids, retroviruses and adenoviruses.l-3 But the safety of those vectors is poor, which has become a serious concern. Besides immunogenicity caused by viral vectors, a further problem is that viral vectors show a preference to integrate into the transcription or control region of active genes, which may induce tumors and other disorders. 展开更多
关键词 human-derived vector site-specific integration targeting expression vascular endothelial growth factor 165
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部